Beth Apsel Winger, MD, PhD
Wednesday, February 15, 2023, 4:00-5:00 pm (San Francisco)
In this session, Dr. Winger discussed:
- Review of chelators
- Challenges in dosing infants
- Model-based dosing
This seminar is part of the International Alpha Thalassemia Consortium quarterly series, which is focused on alpha thalassemia major (ATM) and intended to build an international consortium of experts in hematology, maternal-fetal medicine, genetics, fetal therapy, and neonatology to improve care for patients with ATM. Each session is dedicated to a single speaker/topic and lasts one hour, including a 30-minute presentation, followed by moderated discussion.